Eastland Julia Marie
SEC-identified person · CIK 1500189 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Lantheus Holdings, Inc. LNTH | Director | filed 2024 - 2026 |
| Zentalis Pharmaceuticals, LLC ZNTL | Director · CEO & President | filed 2024 - 2026 |
| Dynavax Technologies Corp dvax | Director | filed 2020 - 2024 |
| Harpoon Therapeutics, Inc. HARP | Director · President and CEO | filed 2019 - 2024 |
| Graybug Vision, INC. GRAY | Director | filed 2020 - 2023 |
| Oncothyreon Inc. ONTY | CFO AND VP CORP DEVELOPMENT | filed 2010 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.